Miklós Idei

A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.

G Kéri, J. Érchegyi, Anikó Horváth et al. · Proceedings of the National Academy of Sciences · 1996 · 97 citations

Tumor Biology, Oncology, Tumor-selective Somatostatin Analog +14

Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells.

Ferenc Hollósy, György Mészáros, Gyöngyi Bökönyi et al. · PubMed · 2001 · 42 citations

Tumor Biology, Urology, Chemoprevention Strategy +11

Novel Lipoamino Acid- and Liposaccharide-Based System for Peptide Delivery:  Application for Oral Administration of Tumor-Selective Somatostatin Analogues

István Tóth, John P. Malkinson, Nicholas Flinn et al. · Journal of Medicinal Chemistry · 1999 · 41 citations

Cell-based Drug Delivery, Peptide Delivery, Lipid Preparation +15

Relationship between lipophilicity and antitumor activity of molecule library of Mannich ketones determined by high-performance liquid chromatography, clogP calculation and cytotoxicity test

Ferenc Hollósy, Tamás Lóránd, László Őrfi et al. · Journal of Chromatography B · 2002 · 37 citations

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +10

Novel Somatostatin Analogs with Tyrosine Kinase Inhibitory and Antitumor Activity

Gÿorgý Kéri, Imre Mező, Anikó Horváth et al. · Biochemical and Biophysical Research Communications · 1993 · 37 citations

Medicinal Chemistry, Medicine, Receptor Tyrosine Kinase +8